Patent Foramen Ovale Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Fibrillation or Tachycardia
Conditions: Patent Foramen Ovale; Atrial Fibrillation; Cryptogenic Stroke Intervention: Drug: Flecainide Sponsors: Assistance Publique - Hôpitaux de Paris; Fonds de dotation ACTION Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2022 Category: Research Source Type: clinical trials
Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Fibrillation or Tachycardia
Conditions: Patent Foramen Ovale; Atrial Fibrillation; Cryptogenic Stroke Intervention: Drug: Flecainide Sponsors: Assistance Publique - Hôpitaux de Paris; Fonds de Dotation ACTION Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2022 Category: Research Source Type: clinical trials
Risk of Ischaemic Stroke After Pulmonary Embolism in Patients With and Without Patent Foramen Ovale
Condition: Foramen Ovale, Patent Intervention: Sponsor: University Hospital, Brest Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 3, 2021 Category: Research Source Type: clinical trials
